Only 6 Weeks until Investment In Innovation (In3) Europe in Paris, April 29-30, Presented by Medtech Insight, a Division of Windhover Conferences

Published: Mar 18, 2009

IRVINE, Calif.--(BUSINESS WIRE)--Medtech Insight, a division of Windhover Conferences--Investors and large company partners such as Abbott Laboratories, Abingworth Management Ltd., Bard Ltd., Boston Scientific EarlyBird Ventures, Edmond de Rothschild Investment Partners, Edwards Lifesciences Corporation, Kimberly-Clark Health Care, Matignon Technologies FCPR, Medtronic Europe Sarl, Paul Capital Partners, Pitango Venture Capital, Rothschild Gestion-Paris, Sanofi-Aventis Deutschland GmbH, Sofinnova Partners and more have already decided to send their teams to Europe’s best strategic partnering and investment event. “Investment In Innovation (In3) Europe” conference, being held April 29-30, 2009 at The Marriott Rive Gauche Hotel in Paris, France, is a do-not-miss worldwide med device event for those looking to partner, invest and network with the most promising medical technology companies.

Back to news